BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7788848)

  • 1. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol.
    Bosland MC; Ford H; Horton L
    Carcinogenesis; 1995 Jun; 16(6):1311-7. PubMed ID: 7788848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone.
    Han X; Liehr JG; Bosland MC
    Carcinogenesis; 1995 Apr; 16(4):951-4. PubMed ID: 7728979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence and histogenesis of seminal vesicle adenocarcinoma and lower incidence of prostate carcinomas in the Lobund-Wistar prostate cancer rat model using N-nitrosomethylurea and testosterone.
    Tamano S; Rehm S; Waalkes MP; Ward JM
    Vet Pathol; 1996 Sep; 33(5):557-67. PubMed ID: 8885183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
    Ofner P; Bosland MC; Vena RL
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of invasive carcinomas in the accessory sex organs other than the ventral prostate of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.
    Shirai T; Tamano S; Kato T; Iwasaki S; Takahashi S; Ito N
    Cancer Res; 1991 Feb; 51(4):1264-9. PubMed ID: 1997167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats.
    Yu M; Leav BA; Leav I; Merk FB; Wolfe HJ; Ho SM
    Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of proliferative lesions of ventral prostate, seminal vesicle, and other accessory sex glands in rats by N-methyl-N-nitrosourea: effect of castration, pretreatment with cyproterone acetate and testosterone propionate and rat strain.
    Bosland MC; Prinsen MK; Rivenson A; Silverman J; Fiala E; Williams GM; Kroes R; Weisburger JH
    Prostate; 1992; 20(4):339-53. PubMed ID: 1535126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone propionate.
    Bosland MC; Prinsen MK
    Cancer Res; 1990 Feb; 50(3):691-9. PubMed ID: 2137026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.
    Ozten N; Horton L; Lasano S; Bosland MC
    Cancer Prev Res (Phila); 2010 Mar; 3(3):371-80. PubMed ID: 20179302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for the study of prostate carcinogenesis.
    Bosland MC
    J Cell Biochem Suppl; 1992; 16H():89-98. PubMed ID: 1289679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobe specific effects of testosterone and estrogen on 3,2'-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis.
    Yaono M; Tamano S; Mori T; Kato K; Imaida K; Asamoto M; Shirai T
    Cancer Lett; 2000 Mar; 150(1):33-40. PubMed ID: 10755384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats.
    Tam NN; Szeto CY; Sartor MA; Medvedovic M; Ho SM
    Neoplasia; 2008 Jan; 10(1):20-40. PubMed ID: 18231636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicology and carcinogenesis studies of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Jan; (545):1-240. PubMed ID: 18685716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal and genotoxic estrogen-androgen carcinogenesis in the NBL rat prostate: A role for aromatase.
    Bosland MC; Vega K; Horton L; Schlicht MJ
    Prostate; 2023 Jun; 83(9):823-830. PubMed ID: 36938936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of perinatal exposure to bisphenol A on induction of prostate cancer in Sprague Dawley rats by MNU and testosterone.
    Bosland MC; Schlicht MJ; Acevedo N; Soto AM; Prins G
    Toxicology; 2023 Jan; 484():153394. PubMed ID: 36521576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multistage prostate carcinogenesis: the role of hormones.
    Bosland MC; Dreef-Van Der Meulen HC; Sukumar S; Ofner P; Leav I; Han X; Liehr JG
    Princess Takamatsu Symp; 1991; 22():109-23. PubMed ID: 1844235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression.
    Prins GS
    Endocrinology; 1992 Jun; 130(6):3703-14. PubMed ID: 1597166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Estrogen in Androgen-Induced Prostate Carcinogenesis in NBL Rats.
    Ozten N; Vega K; Liehr J; Huang X; Horton L; Cavalieri EL; Rogan EG; Bosland MC
    Horm Cancer; 2019 Jun; 10(2-3):77-88. PubMed ID: 30877616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.